Effects of Pioglitazone on Reverse Cholesterol Transport and HDL Function in Persons With Diabetes.
Phase of Trial: Phase III
Latest Information Update: 10 Dec 2014
At a glance
- Drugs Pioglitazone (Primary)
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Mar 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 13 Jul 2010 New trial record